Golden Cross Stocks — Overview View · Biological Products, (No Diagnostic Substances)
5 stocks match the Golden Cross Stocks screen. Stocks whose 50-day moving average has just crossed above their 200-day — a classic bullish trend signal. Overview columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–5 of 5
| GILD | Gilead Sciences | Healthcare | Biological Products, (No Diagnostic Substances) | $187.5B | -57.87 | 151.21 | +1.09% | Strong Buy | 186K |
| CRSP | Crispr Therapeutics Ag | Healthcare | Biological Products, (No Diagnostic Substances) | $5.5B | -12.10 | 56.47 | -0.79% | Buy | 71K |
| NVAX | Novavax Inc | Healthcare | Biological Products, (No Diagnostic Substances) | $1.7B | -6.88 | 10.34 | +0.19% | Buy | 229K |
| ZURA | Zura Bio Ltd | Healthcare | Biological Products, (No Diagnostic Substances) | $563M | -6.57 | 5.88 | +3.52% | Buy | 81K |
| LIMN | Liminatus Pharma, Inc. | Healthcare | Biological Products, (No Diagnostic Substances) | $248M | -19.84 | 3.70 | -2.89% | Strong Buy | 293 |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.